Jardy Tablets

Jardy Tablets contain Empagliflozin, an SGLT2 inhibitor used for the management of type 2 diabetes mellitus, helps lower blood glucose by promoting urinary glucose excretion, supports cardiovascular protection, and may help reduce the risk of heart failure and kidney complications in diabetic patients, providing effective long-term glycemic control when used along with diet and exercise.

Dosage:
Usual dose is once daily as prescribed by the physician, may be taken with or without food, dosage depends on patient condition and blood glucose response.

Side Effects:
Common: increased urination, thirst, urinary tract infections, genital fungal infections, nausea,
Less common / serious: dehydration, low blood pressure, ketoacidosis, kidney function changes, allergic reactions,
Precautions: use with caution in patients with kidney disease or dehydration, maintain adequate fluid intake, monitor blood glucose regularly under medical supervision.